News
BioMarin, Ascendis Resolve Global Yuviwel Patent Disputes
Ascendis Pharma will pay royalties to BioMarin on Yuviwel sales in the US, EU, Brazil and South Korea.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Ascendis Pharma will pay royalties to BioMarin on Yuviwel sales in the US, EU, Brazil and South Korea.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
